Trial Profile
Clinical Trials Insight: 700030444
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2008
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Hernia; Postoperative pain
- Focus Therapeutic Use
- Sponsors DURECT Corporation
- 08 Feb 2008 New trial record.